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            Atrial fibrillation (AF), the most common arrhythmia in adults, affects 1 in 25 people 
over the age of 60 years and 1 in 10 over the age of 80 years.1  There is considerable morbidity, 
mortality and economic burden associated with AF, all of which will increase with the 
expanding elderly population. Until recently, pharmacologic therapy with AV nodal blocking 
agents, antiarrhythmics and anticoagulation were the mainstay of therapy. Although electrical 
cardioversion is associated with a high immediate success rate, most patients have recurrences of 
AF with only 23% remaining in sinus rhythm one year after cardioversion.2  Antiarrhythmic 
agents have been shown to improve sinus maintenance, but these medications have variable 
success and are associated with many potentially serious side effects. In addition, the recently 
published AFFIRM trial suggests that a pharmacological rhythm control strategy has no benefit 
in terms of mortality or morbidity over a rate control and anticoagulation strategy.3 Over the last 
few years, there has been a great deal of enthusiasm regarding catheter based ablation strategies 
aimed at curing AF.
Percutaneous Maze Procedure
            In 1959 Moe theorized that AF resulted from multiple wavelets of reentry. With this in 
mind, Cox performed the surgical Maze procedure in 1991.4 The Maze procedure alters the 
arrhythmogenic substrate by interrupting the macroreenterant circuits and reducing the critical 
mass of atria needed to sustain AF. This surgical approach currently is preformed in association 
with coronary bypass surgery and/or mitral valve repair and is successful in curing AF in 75-
90% of cases.5  Although the surgical procedure has been modified over time, the approach has 
consistently included isolation of the pulmonary veins (PV). Currently, malleable hand-held 
catheters are being used to create linear lesions with conventional radiofrequency energy, rather 
than surgical incisions.
            The surgical experience over the past decade has provided evidence that the left atrium 
plays a significant role in the maintenance of AF and that a reduction in the left atrial mass 
prevents maintenance of AF. Because an open chest procedure is associated with significant 
morbidity, attempts have been made to replicate the Maze procedure using a percutaneous, 
catheter-based approach. The MECA (Multiple Electrode Catheter Ablation) trial, sponsored by 
Boston Scientific/EP technologies, was designed to determine the safety and feasibility of 
specially designed catheters with multiple large electrodes used to create circular, biatrial linear 
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endocardial lesions to treat atrial fibrillation (Figures 1-3). The concept and catheter design were 
based on encouraging animal data.6 However, the MECA study was terminated prematurely due 
to a relatively high complication rate and low efficacy rate.7   Additional limitations of a 
percutaneous Maze procedure include a long, technically difficult procedure associated with 
long fluoroscopy times and the risk of proarrhythmia in the form of atrial tachycardias,  which 
likely occur due to conduction gaps in the ablation lines. The role of linear atrial lesions in the 
treatment of atrial fibrillation remains unresolved.
 
Figure   1.   A   specially-designed,   multiple-electrode  loop   ablation  catheter   (EP 
Technologies) is shown deployed in the left atrium during an endocardial, catheter-
based Maze procedure. The view is left anterior oblique. The catheter emerges from 
the transeptal sheath and a loop is created after the tip of the catheter is pulled to the 
end of the sheath with a pull-wire as the body of the catheter is advanced into the 
atrium. There are 14 individual ablation coils on the catheter. Coils number 1, 4, 7, 8, 
11, and 14 are more radiopaque to improve identification. An intracardiac echo probe 
can be seen in the body of the right atrium. 
Importance of the Pulmonary Veins 
            Embryologically, the PVs form as a bud that grows from the heart towards the lungs. As 
a result, the PVs have a sleeve of muscle fibers that surround them. In the late 1990’s, 
Haissaguerre made a critical observation that the muscle fibers associated with the PVs are an 
important source of ectopic beats capable of triggering AF.8  This discovery led to a revolution 
in interventional electrophysiology. Pulmonary vein muscle tissue has unique electrophysiologic 
properties and appears to be able to maintain reentry within a relatively small amount of atrial 
muscle mass. This is likely due to the spatial complexity and a short refractory period. This area 
is also a common source of rapid focal discharges. Figure 4 shows an example of a rapid, 
irregular atrial tachycardia arising from a right upper PV that is associated with conduction block 
to the left atrium. The case highlights the unusual electrophysiologic observations that are made 
in the PVs. Although the arrhythmia is an atrial tachycardia in this case rather than AF, it is easy 
to see how a rapidly discharging focus in a PV could lead to AF by causing fibrillatory 
conduction or by initiating reentry in the atrium.
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Figure 2 .  A view of the multiple-electrode loop ablation catheter 
deployed in the left atrium as seen from a phased-array intracardiac 
echo probe located in the right atrium. A subset of the individual 
electrode coils can be identified. Intracardiac echo can be useful 
during left atrial catheter ablation procedures to optimize tissue 
contact.
 
Figure   3.  A   6-electrode   deflectable   ablation   catheter   (EP 
Technologies) is shown during an endocardial catheter-based Maze 
procedure. The view is left anterior oblique. The catheter courses 
along the right atrial septum from the coronary sinus to the anterior 
right atrium. A quadripolar electrode catheter is in the coronary sinus 
and an intracardiac echo probe is in the low right atrium.
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Pulmonary Vein Isolation
            Initially, attempts were made to ablate the ectopic foci in patients who had paroxysmal 
AF that appeared to arise in the PVs. Despite high initial success rates, this approach soon 
proved to be inadequate with recurrence rates over 60%.9,10  The limitations of a focal approach 
include the presence of multiple PV foci, a paucity of spontaneous or inducible AF during the 
procedure, the subsequent development of new foci, and the difficulty in mapping triggers when 
AF is persistent. In addition, delivery of radiofrequency energy deep within the PV can lead to 
PV stenosis (Figure 5).
 
Figure 4. This tracing was recorded in a patient with an irregular, 
paroxysmal atrial tachycardia. Shown are surface recordings (I, II, III, 
V1, and V5) and intracardiac recordings from the high right atrium 
(HRA), the distal (PVd), mid (PVm), and proximal (PVp) electrode 
pairs on a catheter positioned at the ostium of the right superior 
pulmonary vein, and the distal (CSd), mid (CSm), and proximal (CSp) 
coronary sinus. The electrograms recorded at PVd show a rapid 
irregular   pulmonary   vein   tachycardia   from   the   right   superior 
pulmonary vein with 2:1 conduction block to the left atrium. The 
conduction block resolves after a pause just prior to termination of the 
pulmonary vein tachycardia. Radiofrequency energy delivered at this 
site resulted in elimination of the tachycardia.
            Electrical isolation of the pulmonary veins avoids many of the limitations of focal PV 
ablation. By isolating a PV from the atrium without ablating the entire circumference of the PV 
ostium, Haissaguerre and his group developed a technique referred to as ostial segmental PV 
isolation.11 The myocardial sleeves that connect the PV to the left atrium are a complex network 
of fibers. These fibers do not completely encircle the venous os, but are typically located in 
segments or quadrants. Identification of these muscular sleeves allows selective radiofrequency 
(RF) energy delivery, thereby minimizing the risk of PV stenosis. 
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Figure 5. A pulmonary venogram is shown in a 
patient who had a prior focal ablation procedure 
for   atrial   fibrillation   at   which   time 
radiofrequency current was delivered in the left 
inferior   pulmonary   vein.   The   view   is   left 
anterior oblique. The contrast injection shows a 
focal stenosis of a superior branch of the left 
inferior   pulmonary   vein.   A   quadripolar 
electrode   catheter   can   be   seen   in   the   left 
superior pulmonary vein and along the right 
atrial septum. The patient was asymptomatic.
            The procedure requires transeptal catheterization. Intracardiac echocardiography can be 
useful to guide transeptal puncture (Figure 6). Identification of the PV ostia using venography 
or intracardiac echo is important to identify anomalies, such as a common PV ostium (Figure 7), 
and to avoid delivery of RF current in the PVs. Many centers perform a three-dimensional 
cardiac CT scan or MRI prior to ablation to screen for PV variants and to have a baseline 
imaging study in case a patient develops symptoms suggestive of PV stenosis after ablation. In 
order to identify PV potentials, a multiple electrode catheter is positioned near the ostium of the 
PV. This can be accomplished using a basket-type catheter or a circular multipolar mapping 
catheter. An example of a commonly used circular decapolar catheter is shown in figure 8. The 
decapolar catheter is positioned within 5 mm of the PV ostium, and RF energy is delivered at the 
ostial sites that display the earliest bipolar PV potentials during sinus rhythm or during coronary 
sinus pacing, or at sites that have the largest intrinsic deflections in unipolar recordings. 
Utilization of both unipolar and bipolar recordings during segmental ostial ablation is associated 
with increased efficacy and less RF energy delivery.12,13  The endpoint of this procedure is 
elimination or dissociation of pulmonary venous potentials (figure 9-10). PV isolation is usually 
performed during sinus rhythm but can be accomplished during AF when sinus rhythm cannot 
be maintained initially during the procedure (figure 11-12). Initial strategies consisted of 
ablating only the arrhythmogenic PV’s, but empiric isolation of all four PV’s has been shown to 
be associated with a higher success rate. 
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Figure 6. An intracardiac echo image during transeptal 
puncture. The transeptal needle can be seen “tenting” the 
thin part of the intratrial septum. Intracardiac echo can 
be useful to guide transeptal catheterization.
 
Figure 7.  A pulmonary venogram is shown in a patient 
undergoing an ostial segmental pulmonary vein isolation 
procedure. The view is left anterior oblique. The contrast 
injection shows a common ostium of the left upper and 
lower pulmonary veins. There is a quadripolar electrode 
catheter positioned at the roof of the common ostium and 
one positioned in the coronary sinus. 
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Figure 8. An anterior-posterior fluoroscopic view of a decapolar circular 
mapping  catheter   (Lasso,  Biosense  Webster   Inc.)   and  a  deflectable 
quadripolar 4-mm tip ablation catheter positioned at the ostium of the left 
upper pulmonary vein during a segmental ostial pulmonary vein isolation 
procedure. A third electrode catheter is positioned in the coronary sinus.
            Segmental ostial ablation has been associated with high success rates in patients with 
paroxysmal lone atrial fibrillation. Among the first 58 patients treated at the University of 
Michigan, 70% were free from AF recurrences and 83% were free of symptomatic AF or had 
significant improvement at 5 months follow-up.14  Segmental ostial ablation appears to be less 
successful in patients with persistent or permanent AF. Only 22% of patients with persistent AF 
were free from recurrent AF at 5 months.14  This high failure rate suggests that the left atrium 
plays a more important role in patients with persistent AF compared to patients with paroxysmal 
AF.
            Recurrent AF after segmental ablation is likely due to recovery of conduction of the PV 
fibers. Other causes include ectopy arising from a small ostial cuff of muscle proximal to the 
ablation site, or non-PV ectopic foci arising from the superior vena cava, coronary sinus, left or 
right atrium, ligament of Marshall, or rarely the inferior vena cava.15 As a result, 10-40% of 
patients undergoing segmental ostial ablation require a repeat ablation procedure.11,14 
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Figure 9. An example of pulmonary vein potentials (PVPs) recorded at the ostium of 
the right superior pulmonary vein during sinus rhythm prior to pulmonary vein 
isolation. Shown are surface leads I and V5 and bipolar intracardiac electrograms 
recorded by the decapolar circular mapping catheter (LA 1-2 to LA 10-1) and the 
distal (CSd) and proximal (CSp) coronary sinus.  PVd bi and PVd uni represent the 
bipolar and unipolar electrograms recorded from the ablation catheter positioned at 
the ostium of the PV. The PVPs can be distinguished from the left atrial (LA) 
electrogram by their sharp appearance. There are several pulmonary vein potentials 
visible following the LA recording at the PV ostium. The earliest PVP appears to be 
electrode number six as highlighted by the vertical dotted line and was the first site 
targeted with ablation.
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Figure   10.  This   tracing   is   an  example  of   a   pulmonary   vein  potential   with 
spontaneous activity that is dissociated from the left atrium during sinus rhythm after 
partial ostial segmental pulmonary vein isolation. There remains an intact PVP 
recorded at electrodes 2-3 and 10-1. The format and abbreviations are the same as 
for figure 9. 
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Figure 11.  In this example radiofrequency current is delivered near electrode 
number 1 on the circular mapping catheter that is positioned at the ostium of the left 
superior pulmonary vein. There are two pulmonary vein potentials visible during 
atrial fibrillation with the earliest activation seen at LA 1-2 as highlighted by the 
vertical dotted line. All PVPs are eliminated during ablation. The format and 
abbreviations are the same as for figure 9.
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Figure 12. An example of a pulmonary vein potential with spontaneous activity that 
is dissociated from the left atrium during atrial fibrillation is shown after complete 
pulmonary vein isolation. The recording was made at the time that RF current was 
discontinued. The format and abbreviations are the same as for figure 9.
            In experienced centers, the risk of a major complication including PV stenosis, cardiac 
tamponade, stroke and death is approximately 2%.  Measures that are used to minimize the risk 
of PV stenosis include delivery of energy only at the ostium, limitation of the power to 30-35 
watts and temperature to 52˚ C, discontinuation of RF if no effect is seen within 20 seconds, 
periodic pulmonary venography, and intracardiac echo visualization and Doppler measurement. 
Although some degree of PV narrowing may occur following the ablation procedure, clinically 
relevant PV stenosis is rare. Three-dimensional computed tomography has been shown to be 
useful in the identification of pulmonary vein stenosis. A series from the University of Michigan 
found that among 58 consecutive patients who had undergone a segmental ostial isolation 
procedure,   there   were   no   patients   with   symptomatic   PV   stenosis.16   Routine   computed 
tomography scans performed four months following the ablation identified an average narrowing 
of 1.5 mm of the ostial diameter. A 28% to 61% stenosis was present at an average distance of 
7.6 +  2.2 mm from the ostium in only 3% of the 128 PVs treated. The Cleveland Clinic group 
recently reported the results of using routine spiral computed tomography to detect PV stenosis 
following PV isolation ablation procedures17.  In their series of 335 patients, 18 (5%) had severe 
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PV stenosis defined as a luminal narrowing of > 70%.  However, only 10 of the patients (3%) 
were symptomatic with the most prevalent symptom being shortness of breath (8 patients), 
followed by cough (7 patients) and hemoptysis (5 patients).   An awareness of this potential 
complication is important since therapeutic options are available. Balloon angioplasty and 
venous stenting have been performed in symptomatic patients.
            Pulmonary vein isolation was reported initially to be associated with long procedure and 
fluoroscopy times. However, it has been shown that centers that have performed over 75 cases 
can typically complete the procedure in less than 3 hours and with less than 60 minutes of 
fluoroscopy.18
 
Figure 13. Electroanatomic maps of the left atrium during an electroanatomic left 
atrial ablation procedure for atrial fibrillation.  The left superior (LSPV), left inferior 
(LIPV), right superior (RSPV), and right inferior (RIPV) pulmonary veins are 
labeled.  The continuous series of solid red circles encircling the pulmonary veins 
represent radiofrequency ablation sites. Two additional linear lesion sets are shown: 
one connecting the two circular lesions that surround the pulmonary veins, and one 
connecting the mitral valve annulus to the circular lesion that surrounds the left 
pulmonary veins.  (Figure courtesy of Dr. Fred Morady)
 Electroanatomic Left Atrial Ablation 
            An alternative endocardial ablation technique to treat AF has been described by Pappone. 
This technique uses a circumferential electroanatomic approach.19  The procedure described by 
Pappone involves a 3-D electroanatomic mapping system (CARTO, Biosense Webster Inc.) to 
map the atria and PVs. Circumferential RF lesions are then created at 5 mm from the PV ostia.  
This anatomic approach eliminates the need for mapping spontaneous or induced arrhythmias.  
The end point for ablation is a bipolar amplitude less than 0.1 mV inside the lesion and a delay 
of greater than 30ms across the ablation line (figure 13). The one-year success rates, defined as 
freedom from AF, obtained by the Pappone group in 251 patients (paroxysmal AF=179, 
permanent AF=72) treated was 80% overall, with 86% for paroxysmal AF and 68% for 
permanent AF.20  Only 75% of the circumferential lesions surrounding the individual PVs met 
criteria for complete, defined as a bipolar amplitude < 0.1 mV. Interestingly, they found no 
relation between lesion completeness and clinical outcome. This finding led the Pappone and his 
group to use the term “electroanatomic remodeling” to describe the alteration in the atria 
substrate that occurs during this ablation technique which prevents atrial fibrillation. This Andre 
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approach of PV isolation plus substrate modification may explain the higher success rates 
obtained compared to exclusively isolating the PV and eliminating the “trigger” of AF in the 
segmental ostial ablation approach.  Which of these two approaches is superior is a source of 
debate. A randomized control trial comparing segmental ostial ablation to circumferential 
ablation in patients with paroxysmal AF is currently underway.
Conclusions
             The last few years have marked the beginning of an exciting new era in the treatment for 
AF.  For patients with paroxysmal AF, both segmental and circumferential ablations appear to 
have comparable long term success rates and low rates of complications. However, for patients 
with   persistent   or   permanent   AF,   the   circumferential   ablation   approach   using   3D-
elcctroanatomic mapping appears to be more successful. Patients with AF who are suitable 
candidates   for   catheter   ablation   are   those   with   symptomatic   AF   despite   reasonable 
pharmacologic efforts and minimal structural heart disease. The future of ablation therapy for 
AF will likely be an approach which both eliminates the trigger of AF and alters the substrate 
which permits maintenance of the arrhythmia. New catheter designs and alternative energy 
sources are currently under investigation to improve the safety, efficiency, and success rate of 
catheter ablation for AF.
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